August 7, 2025BJU InternationalOpen Access

What has the COVID‐19 pandemic taught us about safety of surgical wait times in urological oncology?

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis reveals surgical delays affect patient outcomes in urological oncology, indicating a need for timely procedures.

Surgical delays during the COVID-19 pandemic can negatively impact clinical outcomes in urological oncology.
Studies show 2 to 3 months of delay in urothelial cancer treatment resulted in worse outcomes for patients.
Most prostate cancer treatments can safely be deferred for up to 180 days without significant negative effects.
Urgent procedures like nephrectomy for aggressive tumors should occur within 30 days to ensure patient safety.

Blackmur et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark